Andreas Glenth News Today

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease, Compared to the Placebo Arm; Data Support

19.08.2022 - – In Adults with Pyruvate Kinase (PK) Deficiency Who Are Regularly Transfused, PYRUKYND Demonstrated a Statistically Significant and Clinically Meaningful Reduction in Transfusion Burden – – Following FDA Approval in February, PYRUKYND Is the First ... Seite 1

– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Regularly Transfused, PYRUKYND® Demonstrated a Statistically Significant and Clinically Meaningful...